FIGS has recently seen its consensus analyst price target rise from $6.74 to $7.74 per share as a result of improving growth expectations. This update follows increased optimism around the company's brand strength, growing demand, and flexible financial position, while remaining balanced against ongoing valuation concerns and market competition. Stay tuned to discover how you can keep up with the shifting narrative and what these evolving projections might mean for FIGS in the months ahead.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value FIGS.

Recent analyst commentary on FIGS stock illustrates a mix of optimism and measured caution, with institutions weighing the company’s brand momentum and financial health against prevailing valuation concerns.

???? Bullish Takeaways

BTIG initiated coverage with a Buy rating and a $9 price target, emphasizing confidence in FIGS’s strong brand position and demand trends in the U.S. healthcare apparel market. The analyst also praised the company’s debt-free balance sheet, indicating a flexible financial foundation that can support ongoing growth.

Analysts at Raymond James, following meetings with FIGS management, highlighted positive operating momentum extending from the first half into the second half of 2025. Reduced discounting yielded better-than-expected results. Although the firm maintained a Market Perform rating, the outlook signaled robust long-term prospects rooted in improved execution and cost discipline.

???? Bearish Takeaways

Goldman Sachs raised its price target on FIGS from $5 to $5.50 but kept a Sell rating, underscoring persistent caution around the stock’s valuation and competitive pressures. The minor upward revision reflects some recognition of strengths but signals continued reservations about upside potential.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

FIGS, Inc. has released updated earnings guidance for the full year 2025, now projecting net revenue growth of roughly 7 percent compared to 2024.

The company announced an expanded partnership with Team USA and will outfit over 150 healthcare professionals at the Milano Cortina 2026 Olympic and Paralympic Winter Games. This will be the first time FIGS outfits medical teams for a Winter Games.

FIGS introduced FIBREx, a new innovation in fabric designed to offer improved performance and durability. The new material will make its debut in the official Team USA Medical Team kit created for the upcoming Winter Games collection.

Consensus Analyst Price Target has increased from $6.74 to $7.74 per share, reflecting improved growth expectations.

Discount Rate has risen slightly from 8.48 percent to 8.59 percent, indicating a modest adjustment in risk assumptions.

Revenue Growth forecasts have climbed from 4.86 percent to 6.82 percent, suggesting stronger anticipated topline expansion.

Net Profit Margin is projected lower, moving from 5.64 percent down to 4.32 percent. This implies expectations for tighter profitability.

Future P/E Ratio has increased substantially, from 33.71x to 48.34x. This indicates a higher valuation multiple on expected future earnings.

Narratives offer a smarter way to invest by combining the story behind a company with financial forecasts and fair value estimates. On Simply Wall St’s Community page, millions of users access Narratives, which are dynamic summaries that update as new events unfold. By connecting business insights, such as revenue drivers or risks, directly to the numbers, Narratives help you decide when the price is right to buy or sell. This user-friendly tool shows you exactly how changing news or earnings affect what really matters: a stock’s true value.

Read the original FIGS Narrative on Simply Wall St to stay ahead of key developments:

Get timely updates on FIGS’ push for international growth, product innovation, and expanding customer loyalty.

See how industry shifts such as healthcare jobs growth, e-commerce trends, and cost management impact earnings and fair value.

Monitor evolving risks, including new tariffs and rising competition, so you can respond as the outlook for FIGS changes in real time.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include FIGS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com